Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing Cell and Tissue Research Springer Nature Link Comparing Rapid BPC 157 and Time Release for Gut Health Theres a lot of confusion about the difference between BPC 157 arginate and acetate forms, so lets clear that up. The key distinction comes down to stability in the gut. This only applies to oral BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or